PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - O’Neil, Patrick
TI  - Liraglutide Leads to Increased Weight Loss Response in Patients Without Diabetes
DP  - 2015 Jun 18
TA  - MD Conference Express
PG  - 13--14
VI  - 15
IP  - 4
4099  - http://mdc.sagepub.com/content/15/4/13.short
4100  - http://mdc.sagepub.com/content/15/4/13.full
AB  - Indicated for use in patients who were overweight (body mass index ≥ 27 kg/m2 with ≥ 1 comorbidities) or obese (body mass index ≥ 30 kg/m2) without diabetes mellitus, liraglutide has proven safe and effective in the SCALE–Obesity and Prediabetes trial. Combined with diet and exercise, liraglutide can improve weight and health-related quality-of-life factors.